×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Biomarker: Flutemetamol (Vizamyl)
biomarker
2,213 words
KG: FLUTEMETAMOL
2026-03-25
kind:biomarker
section:biomarkers
state:published
amyloid PET
Contents
Flutemetamol (Vizamyl)
🔬
Protein Info
Gene Symbol
FLUTEMETAMOL
Summary
FDA-approved amyloid PET imaging agent for visualization of beta-amyloid plaques in Alzheimer's disease diagnosis
Databases
GeneCards
UniProt
NCBI Gene
HPA
STRING
Knowledge Graph
Related Hypotheses (6)
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.51
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Retinal Vascular Microcirculation Rescue
Score: 0.54
Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat
Score: 0.50
Show 1 more
Related Analyses (5)
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived